Martin Auster, Chief Financial Officer at Ventyx Biosciences, Inc. (VTYX), sold 56,000 shares at $34.95 ($1.9M) on 2023-06-06, disclosed to the SEC on 2023-06-07.
Open-market sale of $1.9M VTYX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.59 | 24,246 | $839K | 43.2% |
| 2 | $34.59 | 24,246 | $839K | 43.2% |
| 3 | $34.95 | 3,754 | $131K | 6.8% |
| 4 | $34.95 | 3,754 | $131K | 6.8% |
| Total | $34.64 avg | 56,000 | $1.9M | 100% |
| Filing → |
| VTYX | SELL | 2023-07-26 | $995K | — | Filing → |
| VTYX | SELL | 2023-04-27 | $2.1M | — | Filing → |
| VTYX | SELL | 2023-04-19 | $231K | — | Filing → |